CASELLI, Emilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.627
AS - Asia 4.641
EU - Europa 4.015
SA - Sud America 632
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 93
OC - Oceania 11
Totale 19.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.333
SG - Singapore 1.381
CN - Cina 1.240
IT - Italia 1.135
GB - Regno Unito 827
SE - Svezia 508
VN - Vietnam 507
HK - Hong Kong 491
BR - Brasile 463
DE - Germania 370
BD - Bangladesh 218
RU - Federazione Russa 207
KR - Corea 191
FI - Finlandia 187
FR - Francia 170
UA - Ucraina 161
CA - Canada 141
TR - Turchia 131
IN - India 113
ID - Indonesia 69
BG - Bulgaria 66
JP - Giappone 63
BE - Belgio 60
NL - Olanda 58
MX - Messico 56
IE - Irlanda 50
PL - Polonia 47
ES - Italia 41
AR - Argentina 38
IQ - Iraq 35
PK - Pakistan 30
RO - Romania 30
CO - Colombia 27
EC - Ecuador 27
ZA - Sudafrica 24
LT - Lituania 23
VE - Venezuela 22
AT - Austria 20
MA - Marocco 20
AE - Emirati Arabi Uniti 19
IL - Israele 19
CL - Cile 18
MY - Malesia 18
CR - Costa Rica 17
UZ - Uzbekistan 14
SA - Arabia Saudita 13
HN - Honduras 12
PE - Perù 12
JM - Giamaica 11
KZ - Kazakistan 11
NI - Nicaragua 11
TW - Taiwan 11
SV - El Salvador 10
AZ - Azerbaigian 9
GT - Guatemala 9
PY - Paraguay 9
SC - Seychelles 9
BO - Bolivia 8
JO - Giordania 8
KE - Kenya 8
MD - Moldavia 8
PH - Filippine 8
TN - Tunisia 8
AU - Australia 7
TH - Thailandia 7
CH - Svizzera 6
AL - Albania 5
DZ - Algeria 5
ET - Etiopia 5
GP - Guadalupe 5
PR - Porto Rico 5
QA - Qatar 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
CI - Costa d'Avorio 4
CW - ???statistics.table.value.countryCode.CW??? 4
CZ - Repubblica Ceca 4
EE - Estonia 4
EG - Egitto 4
IR - Iran 4
LB - Libano 4
NO - Norvegia 4
NP - Nepal 4
PS - Palestinian Territory 4
BH - Bahrain 3
DK - Danimarca 3
GR - Grecia 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HU - Ungheria 2
KW - Kuwait 2
LV - Lettonia 2
MK - Macedonia 2
Totale 18.999
Salva come PNG Salva come JPEG
Città #
Ashburn 1.166
Singapore 882
Santa Clara 832
Chandler 517
Hong Kong 476
Fairfield 475
Hefei 454
Woodbridge 448
San Jose 444
Southend 419
Council Bluffs 392
Jacksonville 306
Ann Arbor 263
Nyköping 262
Houston 244
London 215
Cambridge 209
Dearborn 206
Seattle 200
Beijing 193
Wilmington 191
Los Angeles 190
Modena 180
Ho Chi Minh City 150
Dallas 137
Helsinki 135
Seoul 131
The Dalles 119
Chicago 117
New York 114
Hanoi 112
Berlin 108
Milan 103
Princeton 64
Sofia 61
São Paulo 58
Lauterbourg 55
Washington 55
San Diego 54
Buffalo 52
Redwood City 52
Eugene 48
Shanghai 48
Des Moines 47
Dublin 47
Phoenix 44
Columbus 43
Frankfurt am Main 42
Izmir 42
Tokyo 41
Jakarta 40
Moscow 40
Salt Lake City 39
Brussels 38
Reggio Emilia 37
Warsaw 36
Atlanta 35
Bologna 33
Parma 33
Amsterdam 32
Orem 30
Mexico City 28
Munich 28
Toronto 28
Yalova 28
Florence 27
Rome 27
Boardman 26
Brooklyn 26
Da Nang 22
Elk Grove Village 22
Tampa 22
Chennai 21
Montreal 21
Timisoara 21
Turin 21
Boston 20
Vancouver 20
Falls Church 19
Guangzhou 19
Menlo Park 19
Nuremberg 19
Denver 18
Haiphong 18
Pedara 18
Fuzhou 17
San Francisco 17
Bremen 16
Fremont 16
Kent 16
Norwalk 16
Austin 15
Formigine 15
Seongnam 15
Dong Ket 14
Ghent 14
North Bergen 14
San José 14
Brasília 13
Dhaka 13
Totale 12.399
Salva come PNG Salva come JPEG
Nome #
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening 1.046
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 919
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 437
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 420
Chemo-enzymatic synthesis of levodropropizine 414
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 397
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 387
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 379
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 370
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 367
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 352
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 350
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 350
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 345
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 343
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 335
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 331
Nanomolar inhibitors of AmpC beta-lactamase 330
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 328
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 328
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 327
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 323
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 319
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 315
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 302
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 287
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 285
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 284
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 280
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 277
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 274
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 274
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 269
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 267
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 267
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 266
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 264
Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase 255
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 249
Recognition and resistance in TEM beta-lactamase 246
Structure-based optimization of cephalotin analogue boronic acids as beta-lactamase inhibitors 245
Using Boronic Acid Transition State Inhibitors to understand the extended spectrum (ES) and carbapenemase phenotypes of class A beta-lactamases in Klebsiella pneumoniae 242
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase 237
Exploring novel inhibitors of FOX-4 Class C β-lactamase 230
Stereoselective synthesis of erythro beta-substituted aspartates 230
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases 226
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs 220
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design 215
The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV β-lactamase: A study of Ambler position Asn276 207
Structures of FOX-4 cephamycinase in complex with transition-state analog inhibitors 206
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum 204
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates 202
Structure-based design and solid phase synthesis of novel AmpC b-lactamase inhibitors 200
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 195
Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog 192
Structure-Based Design and In Parallel Synthesis of Boronic Acid Inhibitors of AmpC 61538;-Lactamase 187
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii 184
Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor 182
Progettazione, Sintesi ed Attività di Acidi 1-Acilamminoalcanboronici Inibitori di beta-Lattamasi 178
Interactions of Oxyimino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42 176
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry 169
Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery? 165
Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030 129
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas-derived cephalosporinase 128
Structural Studies of Inhibition of β-Lactamases by Boronic Acid Transition State Analogs and a Penam Sulfone 116
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb) 104
Boronic Acid Inhibitors of β‐Lactamases: A Promising Strategy Against Antimicrobial Resistance 28
Totale 19.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022859 0 0 0 0 68 109 48 88 144 88 187 127
2022/20231.532 186 174 113 161 173 222 38 120 180 20 55 90
2023/2024988 38 76 49 104 186 92 143 78 26 32 53 111
2024/20253.060 110 65 70 178 536 456 205 228 301 84 337 490
2025/20266.283 376 334 587 784 876 516 665 232 532 621 417 343
2026/20271.944 276 382 446 694 146 0 0 0 0 0 0 0
Totale 19.155